Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleClinical Studies

Serum Thymidine Kinase 1 – Potential Prostate Cancer Biomarker: A Clinical Study

JAKUB REZAC, LENKA HANOUSKOVA, STEPAN VESELY, KAREL KOTASKA, ALZBETA KANTOROVA, ANNA LINHARTOVA, VOJTECH FIALA, VIKTOR SOUKUP and OTAKAR CAPOUN
Anticancer Research April 2023, 43 (4) 1675-1680; DOI: https://doi.org/10.21873/anticanres.16319
JAKUB REZAC
1Department of Urology, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
LENKA HANOUSKOVA
2Department of Medical Chemistry and Clinical Biochemistry, Motol University Hospital, 2nd Faculty of Medicine, Charles University in Prague, Prague, Czech Republic;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
STEPAN VESELY
3Department of Urology, Motol University Hospital, 2nd Faculty of Medicine, Charles University in Prague, Prague, Czech Republic
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
KAREL KOTASKA
2Department of Medical Chemistry and Clinical Biochemistry, Motol University Hospital, 2nd Faculty of Medicine, Charles University in Prague, Prague, Czech Republic;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ALZBETA KANTOROVA
1Department of Urology, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ANNA LINHARTOVA
1Department of Urology, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
VOJTECH FIALA
1Department of Urology, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
VIKTOR SOUKUP
1Department of Urology, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
OTAKAR CAPOUN
1Department of Urology, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: otakar.capoun{at}vfn.cz
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 43 no. 4 1675-1680
DOI 
https://doi.org/10.21873/anticanres.16319
PMID 
36974824

Published By 
International Institute of Anticancer Research
Print ISSN 
0250-7005
Online ISSN 
1791-7530
History 
  • Received January 14, 2023
  • Revision received January 28, 2023
  • Accepted January 31, 2023
  • Published online March 27, 2023.

Copyright & Usage 
Copyright © 2023 International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Author Information

  1. JAKUB REZAC1,
  2. LENKA HANOUSKOVA2,
  3. STEPAN VESELY3,
  4. KAREL KOTASKA2,
  5. ALZBETA KANTOROVA1,
  6. ANNA LINHARTOVA1,
  7. VOJTECH FIALA1,
  8. VIKTOR SOUKUP1 and
  9. OTAKAR CAPOUN1⇑
  1. 1Department of Urology, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic;
  2. 2Department of Medical Chemistry and Clinical Biochemistry, Motol University Hospital, 2nd Faculty of Medicine, Charles University in Prague, Prague, Czech Republic;
  3. 3Department of Urology, Motol University Hospital, 2nd Faculty of Medicine, Charles University in Prague, Prague, Czech Republic
  1. Correspondence to: Otakar Capoun, MD, Ph.D., General Faculty Hospital, Ke Karlovu 6, 128 08, Prague, Czech Republic. Tel: +420 242967847, email: otakar.capoun{at}vfn.cz
View Full Text

Statistics from Altmetric.com

Cited By...

  • 3 Citations
  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

PreviousNext
Back to top

In this issue

Anticancer Research: 43 (4)
Anticancer Research
Vol. 43, Issue 4
April 2023
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Serum Thymidine Kinase 1 – Potential Prostate Cancer Biomarker: A Clinical Study
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
1 + 0 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Serum Thymidine Kinase 1 – Potential Prostate Cancer Biomarker: A Clinical Study
JAKUB REZAC, LENKA HANOUSKOVA, STEPAN VESELY, KAREL KOTASKA, ALZBETA KANTOROVA, ANNA LINHARTOVA, VOJTECH FIALA, VIKTOR SOUKUP, OTAKAR CAPOUN
Anticancer Research Apr 2023, 43 (4) 1675-1680; DOI: 10.21873/anticanres.16319

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Serum Thymidine Kinase 1 – Potential Prostate Cancer Biomarker: A Clinical Study
JAKUB REZAC, LENKA HANOUSKOVA, STEPAN VESELY, KAREL KOTASKA, ALZBETA KANTOROVA, ANNA LINHARTOVA, VOJTECH FIALA, VIKTOR SOUKUP, OTAKAR CAPOUN
Anticancer Research Apr 2023, 43 (4) 1675-1680; DOI: 10.21873/anticanres.16319
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Patients and Methods
    • Results
    • Discussion
    • Acknowledgements
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Potential of Inflammatory and Nutritional Markers and Clinicopathological Factors for Prognostic Prediction in Osteosarcoma
  • Diameter of IPDA Is Associated With Maintenance of Hepatic Arterial Blood Flow in DP-CAR
  • Postoperative Changes in Nutritional Status and their Impact on Post-recurrence Prognosis After Pancreatoduodenectomy in Patients With Biliary Tract Carcinoma: An Age-stratified Analysis
Show more Clinical Studies

Keywords

  • Prostate cancer
  • thymidine kinase 1
  • STK1
  • serum biomarker
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire